STOCK TITAN

Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events

Lifecore Biomedical (NASDAQ: LFCR) will participate at three industry events in Oct–Nov 2025 to engage customers and partners and present expertise in process development.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Lifecore Biomedical (NASDAQ: LFCR) will participate at three industry events in Oct–Nov 2025 to engage customers and partners and present expertise in process development.

Events & details: PODD Conference (Boston) Oct 27–28 — Ryan Swanson, Ph.D., will join a panel titled "Achieving Effective Manufacturing Scaleup for Clinical and Commercial Success" on Oct 28 at 3:35–4:05 p.m. ET; booth 601. CPHI Worldwide (Frankfurt) Oct 28–30 — business development presence; booth 5.0B110. American Pharma Manufacturing & Outsourcing Summit (Boston) Nov 17–18 — business development presence; booth TBD.

For meetings contact info@lifecore.com or Lifecore on LinkedIn and see https://www.lifecore.com/events/ for booth links.

Loading...
Loading translation...
Argus Oct 13 session
+1.69% close to close Open Argus
Details

News Market Reaction – LFCR

On Oct 13, the day this news came out, LFCR closed 1.69% above the previous close.

Data tracked by StockTitan Argus for the Oct 13 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

CHASKA, Minn., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at three upcoming industry events. Details of the company’s activities at these events are as follows:

  • 15th Annual Partnership Opportunities in Drug Development (PODD)
    Conference Dates/Location: October 27-28, 2025, in Boston, MA
    Details: Ryan Swanson, Ph.D., Lifecore’s director of process development, will participate in a panel discussion and the company will host meetings with existing and prospective customers and partners
    Panel Title: Achieving Effective Manufacturing Scaleup for Clinical and Commercial Success 
    Panel Date/Time: 3:35 – 4:05 p.m. Eastern on Tuesday, October 28
    Corporate Booth Number: 601
  • CPHI Worldwide 2025
    Conference Dates/Location: October 28-30, 2025, in Frankfurt, Germany
    Details: Lifecore will have a significant business development and marketing presence, including hosting booth meetings with existing and prospective customers and partners.
    Corporate Booth Number: 5.0B110
  • American Pharma Manufacturing & Outsourcing Summit 2025
    Conference Dates/Location: November 17-18, 2025, in Boston, MA
    Details: Lifecore will have a significant business development and marketing presence, including hosting booth meetings with existing and prospective customers and partners
    Corporate Booth Number: TBD

If you are interested in meeting with the Lifecore team at one of these upcoming events, please contact us at info@lifecore.com or reach out via our LinkedIn account at www.linkedin.com/company/lifecore-biomedical. 

For booth information and links to event websites, consult https://www.lifecore.com/events/

About Lifecore Biomedical

Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com. 



Lifecore Biomedical, Inc. Contact Information:

Vida Strategic Partners
Stephanie Diaz (Investors)
415-675-7401
sdiaz@vidasp.com 

Tim Brons (Media)
415-675-7402
tbrons@vidasp.com 

Ryan D. Lake (CFO)
Lifecore Biomedical
952-368-6244
ryan.lake@lifecore.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Lifecore (LFCR) present at the PODD Conference in 2025?

Lifecore will participate Oct 27–28, 2025; the panel with Ryan Swanson is Oct 28 at 3:35–4:05 p.m. ET.

What is Lifecore's booth number at CPHI Worldwide 2025 for LFCR?

Lifecore will be at booth 5.0B110 at CPHI Worldwide, Oct 28–30, 2025 in Frankfurt.

How can investors or partners schedule a meeting with Lifecore (LFCR) at these events?

Contact info@lifecore.com or reach out via Lifecore's LinkedIn to request meetings.

What topic will Lifecore's director of process development discuss at PODD 2025?

Ryan Swanson will join a panel on Achieving Effective Manufacturing Scaleup for Clinical and Commercial Success.

When and where is the American Pharma Manufacturing & Outsourcing Summit where Lifecore (LFCR) will appear?

The summit is Nov 17–18, 2025, in Boston; Lifecore will have a business development presence and booth details are TBD.

Keep reading